There are no Focus articles on CLTX.
There are no Transcripts on CLTX.
GlobeNewswire (Tue, 4:05PM)
GlobeNewswire (Feb 6, 2014)
CLTX vs. ETF Alternatives
Celsus Therapeutics PLC is a biopharmaceutical company engaged in discovery and development of novel, first-in-class, non-steroidal, synthetic anti-inflammatory drugs. Its product portfolio consists of OPRX, MCF, MRX-5, MRX-4 and MRX-6.
Country: United States